MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...
MSD's efforts to combine cancer immunotherapy Keytruda with its AstraZeneca-partnered PARP drug Lynparza have so far failed – but at last it can point to a partial win in a phase 3 trial. The new data ...
Current local time in Moscow Daylight Time (Moscow Daylight Time time zone). Get information about the Moscow Daylight Time time zone. Local time and date, DST adjusted (where ever daylight saving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback